444P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple-negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trialHan Li, Zhenfeng Shi, Z. Yv et al.|Annals of Oncology|2023Cited by 1